BRUKINSA WM NICE Approval Discussion
Diagnosis, Clinical Features and Indications for WM Therapy
An In-Depth Look at the ASPEN Study – Dr Roger Owen and Dr Shirley D’Sa
Practical Considerations of BRUKINSA – Dr Jaimal Kothari
Current Treatments: BSH Guidelines – Dr Dima El-Sharkawi
Welcome to “Real world experience treating WM and what’s next for CLL” – Dr Robert Mulrooney
Waldenström’s macroglobulinaemia/ lymphoplasmacytic lymphoma: An introduction – Prof George Follows
Case-based panel discussion – Dr Pam McKay
Case-based panel discussion – Dr Sarah Lawless
Case-based panel discussion – Dr Vishal Jayakar
Closing
Date of preparation: January 2025. 0723-BRU-PRC-082